[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AT350726B - Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma - Google Patents

Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Info

Publication number
AT350726B
AT350726B AT640576A AT640576A AT350726B AT 350726 B AT350726 B AT 350726B AT 640576 A AT640576 A AT 640576A AT 640576 A AT640576 A AT 640576A AT 350726 B AT350726 B AT 350726B
Authority
AT
Austria
Prior art keywords
blood
clotifying
preparation
production
blood plasma
Prior art date
Application number
AT640576A
Other languages
English (en)
Other versions
ATA640576A (de
Inventor
Johann Dr Eibl
Otto Dr Schwarz
Fritz Dr Elsinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to AT640576A priority Critical patent/AT350726B/de
Priority to SE7707992A priority patent/SE443511B/xx
Priority to DE2734821A priority patent/DE2734821C3/de
Priority to GB32578/77A priority patent/GB1554051A/en
Priority to US05/822,679 priority patent/US4160025A/en
Priority to FI772408A priority patent/FI57421C/fi
Priority to AR268769A priority patent/AR213861A1/es
Priority to NLAANVRAGE7708872,A priority patent/NL170922C/xx
Priority to CA285,026A priority patent/CA1079191A/en
Priority to CH1022077A priority patent/CH635747A5/de
Priority to FR7725597A priority patent/FR2362633A1/fr
Priority to BE180368A priority patent/BE858031A/xx
Priority to LU78024A priority patent/LU78024A1/xx
Priority to HU77IU288A priority patent/HU180816B/hu
Priority to ES461918A priority patent/ES461918A1/es
Priority to NO772978A priority patent/NO148142C/no
Priority to DK384577A priority patent/DK151932C/da
Publication of ATA640576A publication Critical patent/ATA640576A/de
Application granted granted Critical
Publication of AT350726B publication Critical patent/AT350726B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
AT640576A 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma AT350726B (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
SE7707992A SE443511B (sv) 1976-08-30 1977-07-08 Forfarande for framstellning av ett blodkoaguleringsbefremjande preparat ur humanblodplasma
DE2734821A DE2734821C3 (de) 1976-08-30 1977-08-02 Blutgerinnungsfördernde Präparation und Verfahren zu ihrer Herstellung
GB32578/77A GB1554051A (en) 1976-08-30 1977-08-03 Method of producing a blood-coagulation-promoting preparation from human blood plasma
US05/822,679 US4160025A (en) 1976-08-30 1977-08-08 Method of producing a blood-coagulation-promoting preparation from human blood plasma
FI772408A FI57421C (fi) 1976-08-30 1977-08-10 Foerfarande foer framstaellning av ett preparat ur maenniskoblodplasma med blodets koagulation befraemjande verkan
NLAANVRAGE7708872,A NL170922C (nl) 1976-08-30 1977-08-11 Werkwijze voor het bereiden van een bloedstolling bevorderend preparaat.
AR268769A AR213861A1 (es) 1976-08-30 1977-08-11 Un procedimiento para la obtencion de un preparado fomentador de la coagulacion de la sangre
CA285,026A CA1079191A (en) 1976-08-30 1977-08-19 Method of producing a blood-coagulation-promoting preparation from human blood plasma
CH1022077A CH635747A5 (de) 1976-08-30 1977-08-19 Verfahren zur herstellung einer blutgerinnungsfoerdernden praeparation aus menschlichem blutplasma.
FR7725597A FR2362633A1 (fr) 1976-08-30 1977-08-22 Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain
BE180368A BE858031A (fr) 1976-08-30 1977-08-23 Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain
LU78024A LU78024A1 (de) 1976-08-30 1977-08-25
HU77IU288A HU180816B (en) 1976-08-30 1977-08-26 Process for producing composition from human nlood plasma for improving agglutination of blood
ES461918A ES461918A1 (es) 1976-08-30 1977-08-26 Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano.
NO772978A NO148142C (no) 1976-08-30 1977-08-29 Fremgangsmaate ved fremstilling av et blodkoaguleringsfremmende preparat fra humant blodplasma
DK384577A DK151932C (da) 1976-08-30 1977-08-30 Fremgangsmaade til fremstilling af et blodstoerkningsfremmende praeparat af menneskeligt blodplasma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Publications (2)

Publication Number Publication Date
ATA640576A ATA640576A (de) 1978-11-15
AT350726B true AT350726B (de) 1979-06-11

Family

ID=3585985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Country Status (17)

Country Link
US (1) US4160025A (de)
AR (1) AR213861A1 (de)
AT (1) AT350726B (de)
BE (1) BE858031A (de)
CA (1) CA1079191A (de)
CH (1) CH635747A5 (de)
DE (1) DE2734821C3 (de)
DK (1) DK151932C (de)
ES (1) ES461918A1 (de)
FI (1) FI57421C (de)
FR (1) FR2362633A1 (de)
GB (1) GB1554051A (de)
HU (1) HU180816B (de)
LU (1) LU78024A1 (de)
NL (1) NL170922C (de)
NO (1) NO148142C (de)
SE (1) SE443511B (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410022A (en) * 1992-04-24 1995-04-25 Immuno Aktiengesellschaft Method of producing a factor VIII preparation
US5614493A (en) * 1993-06-18 1997-03-25 Immuno Ag Use of human protein C for prevention and treatment of depositions of thrombocytes
US5614405A (en) * 1991-06-20 1997-03-25 Immuno Aktiengesellschaft Method of determining the virus inactivation capacity of an inactivation treatment
US5639730A (en) * 1992-12-16 1997-06-17 Immuno Aktiengesellschaft Method of producing a virus-safe biological preparation
US5714370A (en) * 1991-11-04 1998-02-03 Immuno Aktiengesellschaft Thrombin and method of producing the same
US5891843A (en) * 1995-08-28 1999-04-06 Immuno Aktiengesllschaft Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use
US7005502B1 (en) 1997-05-28 2006-02-28 Baxter Aktiengesellschaft Pharmaceutical preparation comprising vWF propeptide
WO2011032195A1 (en) 2009-09-16 2011-03-24 Bio-Products & Bio-Engineering Ag Medicinal products for the treatment of blood coagulation disorders containing thrombin-free factor xia concentrate
WO2024012853A1 (de) 2022-07-12 2024-01-18 Biomedizinische Forschung & Bio-Produkte AG Arzneimittel zur förderung der hämostase

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
DE3165600D1 (en) * 1980-01-28 1984-09-27 Baxter Travenol Lab Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
DE3172210D1 (en) * 1980-05-27 1985-10-17 Miles Lab Blood coagulation promoting product and process of preparing same
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
JPS5866054A (ja) * 1981-10-14 1983-04-20 Sekisui Chem Co Ltd 血液検査用容器
JPS58105064A (ja) * 1981-12-17 1983-06-22 Sekisui Chem Co Ltd 血液凝固促進剤
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US5118614A (en) * 1988-01-18 1992-06-02 Tessek Sdruzeni Praha Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
EP0796623B1 (de) * 1996-03-20 2005-05-25 Baxter Aktiengesellschaft Pharmazeutisches Präparat zur Behandlung von Blutgerinnungsstörungen
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
RS20050051A (en) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity
AU2003246448A1 (en) * 2002-07-23 2004-02-16 Bio-Products And Bio-Engineering Aktiengesellschaft Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
DD121793A1 (de) * 1975-07-17 1976-08-20
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614405A (en) * 1991-06-20 1997-03-25 Immuno Aktiengesellschaft Method of determining the virus inactivation capacity of an inactivation treatment
US5864016A (en) * 1991-06-20 1999-01-26 Immuno Aktiengesellschaft Blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatment
US5714370A (en) * 1991-11-04 1998-02-03 Immuno Aktiengesellschaft Thrombin and method of producing the same
US5410022A (en) * 1992-04-24 1995-04-25 Immuno Aktiengesellschaft Method of producing a factor VIII preparation
US5639730A (en) * 1992-12-16 1997-06-17 Immuno Aktiengesellschaft Method of producing a virus-safe biological preparation
US5614493A (en) * 1993-06-18 1997-03-25 Immuno Ag Use of human protein C for prevention and treatment of depositions of thrombocytes
US5891843A (en) * 1995-08-28 1999-04-06 Immuno Aktiengesllschaft Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use
US6013620A (en) * 1995-08-28 2000-01-11 Baxter Aktiengesellschaft Pharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its use
US7005502B1 (en) 1997-05-28 2006-02-28 Baxter Aktiengesellschaft Pharmaceutical preparation comprising vWF propeptide
US7557188B2 (en) 1997-05-28 2009-07-07 Baxter Innovations Gmbh Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide
WO2011032195A1 (en) 2009-09-16 2011-03-24 Bio-Products & Bio-Engineering Ag Medicinal products for the treatment of blood coagulation disorders containing thrombin-free factor xia concentrate
EP2305289A1 (de) 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Medizinische Produkte zur Behandlung von Blutgerinnungsstörungen
US8889624B2 (en) 2009-09-16 2014-11-18 Bio & Bio Licensing Sa Thrombin-free composition containing freeze-dried, virally inactivated FXIa and serpins and/or kininogen
EP2832364A1 (de) 2009-09-16 2015-02-04 Bio & Bio Licensing SA Medizinische Produkte zur Behandlung von Blutgerinnungsstörungen
WO2024012853A1 (de) 2022-07-12 2024-01-18 Biomedizinische Forschung & Bio-Produkte AG Arzneimittel zur förderung der hämostase

Also Published As

Publication number Publication date
NO148142B (no) 1983-05-09
FI57421B (fi) 1980-04-30
NO148142C (no) 1983-08-17
CH635747A5 (de) 1983-04-29
NL170922B (nl) 1982-08-16
AR213861A1 (es) 1979-03-30
FI57421C (fi) 1980-08-11
ES461918A1 (es) 1978-12-16
FR2362633A1 (fr) 1978-03-24
ATA640576A (de) 1978-11-15
CA1079191A (en) 1980-06-10
NL7708872A (nl) 1978-03-02
NL170922C (nl) 1983-01-17
DK151932C (da) 1988-06-20
NO772978L (no) 1978-03-01
SE443511B (sv) 1986-03-03
DK384577A (da) 1978-03-01
FR2362633B1 (de) 1981-06-12
LU78024A1 (de) 1978-01-11
DE2734821A1 (de) 1978-03-02
BE858031A (fr) 1977-12-16
SE7707992L (sv) 1978-03-01
DE2734821B2 (de) 1980-11-06
FI772408A (fi) 1978-03-01
GB1554051A (en) 1979-10-17
DE2734821C3 (de) 1985-03-14
US4160025A (en) 1979-07-03
DK151932B (da) 1988-01-18
HU180816B (en) 1983-04-29

Similar Documents

Publication Publication Date Title
AT350726B (de) Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
LU78996A1 (de) Verfahren zur herstellung von fungiziden mitteln
DD133680A5 (de) Verfahren zur herstellung von polyaetherpolyolen
DD137092A5 (de) Verfahren zur herstellung sehr reiner tonerde
DD132015A5 (de) Verfahren zur herstellung von trans-hexahydro-pyrido-indolen
DD128672A5 (de) Verfahren zur herstellung von m-aryloxybenzaldehyden
DD131019A5 (de) Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides
AT348995B (de) Verfahren zur herstellung von acylcyaniden
DD129777A5 (de) Verfahren zur herstellung von phenoxypropionsaeurederivaten
DD128659A5 (de) Verfahren zur herstellung von 4-androsten-3-onen
AT347926B (de) Verfahren zur herstellung von acylcyaniden
DD129903A5 (de) Verfahren zur herstellung von benzoylcyanid
DD131018A5 (de) Verfahren zur herstellung von 2-chlorsulfinylazetidin-4-onen
DD132013A5 (de) Verfahren zur herstellung von benzoylcyanid
DD133795A5 (de) Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen
AT348509B (de) Verfahren zur herstellung von acylcyaniden
DD130241A5 (de) Verfahren zur herstellung von benzoylcyanid
PT67048A (de) Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen
ATA504577A (de) Verfahren zur herstellung einer arzneimittelzubereitung zur aeusserlichen anwendung
DD129915A5 (de) Verfahren zur herstellung von 7-alkoxy-3-chlormethyl-3-cephemen
DD134085A5 (de) Verfahren zur herstellung von halogenacylamiden
DD129782A5 (de) Verfahren zur herstellung von cholecystokinin-pancreozymin-octapeptidamid-sulfatester
DD128953A1 (de) Verfahren zur herstellung von alkalizellulose
DD128591A5 (de) Verfahren zur herstellung von 2-oxo-1-pyrrolidinen
DD133797A5 (de) Verfahren zur herstellung von trans-5a-aryldecahydrobenzazepinen

Legal Events

Date Code Title Description
ELA Expired due to lapse of time